Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?
Condition: Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors Intervention: Drug: Palbociclib 125mg and Ribociclib 600 mg Sponsor: Namik Kemal University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials